98 related articles for article (PubMed ID: 113472)
1. [Long-term results of radioiodine (131I) treatment in 331 patients with Graves' disease (author's transl)].
Saito S; Sakurada T; Yamamoto M; Yoshida K; Kaise K; Kaise N; Yoshinaga K
Nihon Naika Gakkai Zasshi; 1979 Jul; 68(7):724-32. PubMed ID: 113472
[No Abstract] [Full Text] [Related]
2. Thyroid function in patients with Graves' disease long after 131I therapy.
Inoue K; Okamura K; Shiroozu A; Nakashima T; Yoshinari M; Omae T; Nishitani H
Fukuoka Igaku Zasshi; 1980 Jul; 71(7):408-16. PubMed ID: 6894288
[No Abstract] [Full Text] [Related]
3. [Radioiodine (I-131) treatment of Graves' disease (author's transl)].
Rösler H; Kinser J
Ther Umsch; 1973 Oct; 30(10):717-25. PubMed ID: 4800360
[No Abstract] [Full Text] [Related]
4. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
5. [Follow-up and long-term results of radioiodine therapy in immune hyperthyroidism].
Galvun G
Acta Med Austriaca; 1987; 14(3-4):99-101. PubMed ID: 3425189
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
8. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
Guhlmann CA; Rendl J; Börner W
Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
[TBL] [Abstract][Full Text] [Related]
9. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
[TBL] [Abstract][Full Text] [Related]
11. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
12. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
[TBL] [Abstract][Full Text] [Related]
13. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
Dunkelmann S; Rudolph F; Prillwitz A; Groth P; Schümichen C
Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
[TBL] [Abstract][Full Text] [Related]
14. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease.
Baczyk M; Junik R; Ziemnicka K; Sowiński J
Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
16. Correlation of stress with outcome of radioiodine therapy for Graves' disease.
Stewart T; Rochon J; Lenfestey R; Wise P
J Nucl Med; 1985 Jun; 26(6):592-9. PubMed ID: 3839012
[TBL] [Abstract][Full Text] [Related]
17. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
[TBL] [Abstract][Full Text] [Related]
19. [Radioiodine tretment of Graves' disease (author's transl)].
Konishi J; Kasagi K; Iida Y; Mori T; Torizuka K
Horumon To Rinsho; 1979 Nov; 27(11):1239-43. PubMed ID: 583264
[No Abstract] [Full Text] [Related]
20. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
